General Atlantic
Biotech Investor · 3 portfolio companies
Portfolio
3
Combined Value
$6.1B
Focus Areas
4
Top Stage
Phase 2
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Centessa Pharmaceuticals | $6.1B |
| Verdiva Bio | — |
| Innogene Kalbiotech | — |
Biotech Investor · 3 portfolio companies
| Company | Valuation |
|---|---|
| Centessa Pharmaceuticals | $6.1B |
| Verdiva Bio | — |
| Innogene Kalbiotech | — |